Development of a CRISPR/Cas9 system in Entamoeba histolytica: proof of concept

• Published in: International journal for parasitology 2021-02, Vol.51 (2-3), p.193-200
• Main Authors: Kangussu-Marcolino, Monica Mendes, Morgado, Pedro, Manna, Dipak, Yee, Heather, Singh, Upinder
• Format: Article
• Language: English
• Subjects: CRISPR-Cas Systems; CRISPR/Cas9; Entamoeba histolytica; Entamoeba histolytica - genetics; Gene Editing; Homologous recombination; Humans; Luciferase; Plasmids - genetics; RNA, Guide, CRISPR-Cas Systems - genetics
• ISSN: 0020-7519; 1879-0135
• DOI: 10.1016/j.ijpara.2020.09.005

[Display omitted] •This is the first known demonstration of CRISPR/Cas9 function in Entamoeba histolytica.•Cas9-dependent recombination restores luciferase activity of a mutated luciferase gene.•PCR and sequence analyses of chimeric DNA support phenotypic data. The protozoan parasite Entamoeba histolytica is an important human pathogen and a leading parasitic cause of death on a global scale. The lack of molecular tools for genome editing hinders the study of important biological functions of this parasite. Due to its versatility, the CRISPR (clustered regularly interspaced short palindromic repeat)-Cas9 system has been successfully used to induce site-specific genomic alterations, including in protozoan parasites. In this study, we optimised CRISPR-Cas9 for use as a genetic tool in E. histolytica. We chose a single plasmid approach containing both guide RNA (gRNA) and Cas9 nuclease expression cassettes. The amebic U6 promoter was used to drive the expression of the gRNA and its expression was confirmed by Northern blot analysis. Stable transfectant cell lines were obtained using a destabilising domain of dihydrofolate reductase fused to myc-tagged Cas9 (ddCas9). With this system, we were able to induce ddCas9 expression 16 h following treatment with the small molecule ligand trimethoprim (TMP). Stable cell lines expressing ddCas9 and Luc-gRNA or non-specific (NS)-gRNA were transiently transfected with a plasmid containing a mutated luciferase gene (pDeadLuc) targeted by Luc-gRNA and another plasmid with a truncated luciferase gene (pDonorLuc) to restore luciferase expression and consequent activity. We observed that luminescence signal increased for the cell line expressing Luc-gRNA, suggesting that homologous recombination was facilitated by Cas9 activity. This evidence is supported by the presence of chimeric DNA detected by PCR and confirmed by sequencing of the resulting repaired DNA obtained by homologous recombination. We believe this represents the first report of a CRISPR/Cas9 system use in Entamoeba and provides evidence that this genome editing approach can be useful for genetic studies in this early branching eukaryote.